Chandra Bhagat Pharma Limited (BOM:542934)
India flag India · Delayed Price · Currency is INR
63.00
+3.00 (5.00%)
At close: Nov 16, 2026

Chandra Bhagat Pharma Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
1,7091,163888.052,2141,197940.76
Other Revenue
30.185.0920.5111.3--
1,7391,168908.562,2251,197940.76
Revenue Growth
252.01%28.53%-59.17%85.93%27.21%33.07%
Cost of Revenue
1,466936.95734.812,0831,068814.41
Gross Profit
272.36230.86173.75142.31129.04126.34
Selling, General & Admin
38.6235.729.3629.6818.2521.31
Other Operating Expenses
154.44147.08112.6474.5371.4852.63
Operating Expenses
203.82193.77151.51110.6392.3975.18
Operating Income
68.5437.0922.2431.6936.6651.17
Interest Expense
-17.95-18.78-17.96-12.87-21.75-29.84
Interest & Investment Income
0.360.360.160.070.031.54
Currency Exchange Gain (Loss)
25.1525.156.767.7-0.61-9.29
Other Non Operating Income (Expenses)
-1.25-1.25-1.52-1-0.23-2.53
EBT Excluding Unusual Items
74.8442.579.6825.5814.0911.05
Gain (Loss) on Sale of Investments
----0.01-
Gain (Loss) on Sale of Assets
--2.31---
Pretax Income
74.8442.5711.9925.5814.1111.05
Income Tax Expense
20.2612.113.4110.285.053.08
Net Income
54.5930.468.5815.39.057.97
Net Income to Common
54.5930.468.5815.39.057.97
Net Income Growth
777.57%255.11%-43.95%69.02%13.64%319.54%
Shares Outstanding (Basic)
888888
Shares Outstanding (Diluted)
888888
Shares Change
-0.24%-----
EPS (Basic)
7.274.041.142.031.201.06
EPS (Diluted)
7.274.041.142.031.201.06
EPS Growth
779.68%255.11%-43.95%69.02%13.64%322.37%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
34.9483.15-69.1138.9448.96122.99
Free Cash Flow Per Share
4.6611.02-9.165.166.4916.30
Gross Margin
15.66%19.77%19.12%6.40%10.78%13.43%
Operating Margin
3.94%3.18%2.45%1.42%3.06%5.44%
Profit Margin
3.14%2.61%0.94%0.69%0.76%0.85%
Free Cash Flow Margin
2.01%7.12%-7.61%1.75%4.09%13.07%
EBITDA
78.2647.3931.0636.5637.7751.55
EBITDA Margin
4.50%4.06%3.42%1.64%3.16%5.48%
D&A For EBITDA
9.7310.38.824.871.110.38
EBIT
68.5437.0922.2431.6936.6651.17
EBIT Margin
3.94%3.18%2.45%1.42%3.06%5.44%
Effective Tax Rate
27.07%28.45%28.45%40.18%35.82%27.89%
Revenue as Reported
1,7671,196922.392,3271,200956.96
Advertising Expenses
-2.440.021.03-0.38